Intervention
LY3502970
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownA Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related ComorbiditiesNCT06023095 · 2023-09-21
COMPLETEDA Multiple Dose Study of LY3502970 in Healthy Overweight and Obese ParticipantsNCT05841238 · 2023-04-26
COMPLETEDA Study of LY3502970 in Healthy Overweight and Obese ParticipantsNCT05313802 · 2022-05-26
COMPLETEDA Study of LY3502970 in Japanese Participants With Type 2 Diabetes MellitusNCT05086445 · 2021-11-12
COMPLETEDA Study of LY3502970 in Participants With Obesity or Overweight With Weight-related ComorbiditiesNCT05051579 · 2021-09-29
COMPLETEDA Study of LY3502970 in Participants With Type 2 Diabetes MellitusNCT05048719 · 2021-09-15
COMPLETEDA Study of LY3502970 in Participants With Type 2 DiabetesNCT04426474 · 2020-10-08
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED7
Phase mix
PHASE15
PHASE22
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.